Julio Aguirre-Ghiso, Ph.D., is the Rose C. Falkenstein Chair in Cancer Research. An international leader in cancer cell dormancy and metastasis, he helped guide a major shift in the cancer biology field by investigating how cancer cells hibernate. Dr. Aguirre-Ghiso is the co-leader of the Tumor Microenvironment and Metastasis Program and founding director of the Cancer Dormancy and Tumor Microenvironment Institute at Montefiore Einstein Cancer Center (MECC), as well as a professor of cell biology, of oncology, and of medicine.
Julio Aguirre-Ghiso, Ph.D.
Jacqueline Bello, M.D., is the Zimmer-Hardy Chair of Neuroradiology. Dr. Bello is a professor of radiology and in the Leo M. Davidoff Department of Neurological Surgery at Einstein and director of neuroradiology at Montefiore. She has been elected to Einstein’s Davidoff Society for teaching excellence and is a past president of the New York Roentgen Society, the New York State Radiological Society, and the American Society of Neuroradiology.
Jacqueline Bello, M.D.
Kartik Chandran, Ph.D., is the Gertrude and David Feinson Chair in Medicine. He is a professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein. Dr. Chandran studies how viruses infect cells, and he has led efforts to identify and develop antiviral treatments for such diseases as COVID-19, Ebola, and hantavirus syndromes. He also leads Prometheus, an international consortium established to develop antibody-based therapies for emerging viruses.
Kartik Chandran, Ph.D.
H. Dean Hosgood, Ph.D., M.P.H., is the Atran Foundation Chair in Epidemiology & Population Health. Dr. Hosgood, whose research primarily focuses on cancer and environmental exposures, is an associate professor of epidemiology & population health at Einstein, co-leader of the Cancer Epidemiology Prevention & Control Program of MECC, co-director of the Ph.D. in Clinical Investigation, and director of global environmental health for the Global Health Center.
H. Dean Hosgood, Ph.D., M.P.H.
Jonathan Lai, Ph.D., is the Dan Danciger Professor of Biochemistry. Dr. Lai is a professor of biochemistry whose research involves the application of peptide, protein, and antibody engineering methods for the development of novel immunotherapies and vaccines. An expert in engineering antibodies, he has worked to develop antibody treatments against viruses responsible for such diseases as Ebola, COVID-19, and Chikungunya.